TRYGAPOCE
Live / Applied — Third extension granted (statement of use) (as of 05 Mar 2026)
What this means for you
Not registered yet, but its 16 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98225240
- Mark type
- Stylized text
- Filed
- 16 Oct 2023
- Published for opposition
- 16 Jul 2024
- Attorney of record
- Brian Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for treatment of genetic diseases and disorders; pharmaceuticals for treatment of cardiovascular, metabolic, neurological, and inflammatory diseases and disorders
Owner
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
Prosecution history
- 06 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2026 — SOU EXTENSION 3 GRANTED
- 05 Mar 2026 — SOU EXTENSION 3 FILED
- 05 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Aug 2025 — SOU EXTENSION 2 GRANTED
- 13 Aug 2025 — SOU EXTENSION 2 FILED
- 13 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Feb 2025 — SOU EXTENSION 1 GRANTED